HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1934577Generated: October 25, 2026
Tromethamine hydrochloride → Prostaglandin D2
https://huagongshe.com/reaction/1934577
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tromethamine hydrochloride | HCID 93573 | — |
| Reactant | Magnesium Chloride | HCID 5360315 | — |
| Reactant | (E)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid | HCID 6519333 | — |
| Product | Prostaglandin D2 | HCID 448457 | — |
Reaction Steps
To a binding-reaction solution (50 mM Tris/HCl, pH 7.4, 5 mM MgCl2) (0.2 ml) were added human platelet membrane fraction (0.1 mg) and 5 nM [3H]PGD2 (115 Ci/mmol), and reacted at 4° C. for 90 min. After the reaction completed, the reaction mixture was filtered through the glass fiber filter paper, washed several times with cooled saline, and measured radioactivity retained on the filter paper. The specific binding was calculated by subtracting the non-specific binding (the binding in the presence of 10 μM PGD2) from the total binding. The binding-inhibitory activity of each compound was expressed as concentration required for 50% inhibition (IC50), which was determined by depicting a substitution curve by plotting the binding ratio (%) in the presence of each compound, where the binding ratio in the absence of a test compound is 100%. The results are shown in Table below.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06384075B1 |
|---|
| Source dataset | uspto-grants-2002_05 |
|---|
| ORD ID | ord-064ba7cde3f94bcdb6fcd36fef957712 |
|---|
| Source note | uspto-grants-2002_05 |
|---|